{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T16:03:05Z","timestamp":1788624185116,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T00:00:00Z","timestamp":1628294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T00:00:00Z","timestamp":1628294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["18H02994"],"award-info":[{"award-number":["18H02994"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H05534"],"award-info":[{"award-number":["16H05534"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00223-021-00890-9","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T05:03:18Z","timestamp":1628312598000},"page":"104-116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Zoledronic Acid Deteriorates Soft and Hard Tissue Healing of Murine Tooth Extraction Sockets in a Dose-Dependent Manner"],"prefix":"10.1007","volume":"110","author":[{"given":"Ryohei","family":"Kozutsumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9891-9987","authenticated-orcid":false,"given":"Shinichiro","family":"Kuroshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneteru","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ishisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sawase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,7]]},"reference":[{"key":"890_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"890_CR2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","volume":"2","author":"C Cooper","year":"1992","unstructured":"Cooper C, Campion G, Melton LJ (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285\u2013289","journal-title":"Osteoporos Int"},{"key":"890_CR3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.bone.2005.11.024","volume":"38","author":"JY Reginster","year":"2006","unstructured":"Reginster JY, Burlet N (2006) Osteoporosis: a still increasing prevalence. Bone 38:S4-9","journal-title":"Bone"},{"key":"890_CR4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron R, Ferrari S, Russell RG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48:677\u2013692","journal-title":"Bone"},{"key":"890_CR5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"890_CR6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","volume":"68","author":"TL Aghaloo","year":"2010","unstructured":"Aghaloo TL, Felsenfeld AL, Tetradis S (2010) Osteonecrosis of the jaw in a patient on Denosumab. J Oral Maxillofac Surg 68:959\u2013963","journal-title":"J Oral Maxillofac Surg"},{"key":"890_CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","volume":"48","author":"KH Taylor","year":"2010","unstructured":"Taylor KH, Middlefell LS, Mizen KD (2010) Osteonecrosis of the jaws induced by anti-RANK ligand therapy. Br J Oral Maxillofac Surg 48:221\u2013223","journal-title":"Br J Oral Maxillofac Surg"},{"key":"890_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O\u2019Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, S\u00e1ndor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J, International Task Force on Osteonecrosis of the Jaw (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3\u201323","journal-title":"J Bone Miner Res"},{"key":"890_CR9","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F, American Association of Oral and Maxillofacial Surgeons (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg 72:1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"key":"890_CR10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","volume":"16","author":"J Chang","year":"2018","unstructured":"Chang J, Hakam AE, McCauley LK (2018) Current understanding of the pathophysiology of osteonecrosis of the jaw. Curr Osteoporos Rep 16:584\u2013595","journal-title":"Curr Osteoporos Rep"},{"key":"890_CR11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","volume":"65","author":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons","year":"2007","unstructured":"Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369\u2013376","journal-title":"J Oral Maxillofac Surg"},{"key":"890_CR12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10354-016-0437-2","volume":"166","author":"B Svejda","year":"2016","unstructured":"Svejda B, Muschitz C, Gruber R, Brandtner C, Svejda C, Gasser RW, Santler G, Dimai HP (2016) Position paper on medication-related osteonecrosis of the jaw (MRONJ). Wien Med Wochenschr 166:68\u201374","journal-title":"Wien Med Wochenschr"},{"key":"890_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.11005\/jbm.2015.22.4.151","volume":"22","author":"KM Kim","year":"2015","unstructured":"Kim KM, Rhee Y, Kwon YD, Kwon TG, Lee JK, Kim DY (2015) Medication related osteonecrosis of the jaw: 2015 position statement of the Korean society for bone and mineral research and the Korean Association of Oral and Maxillofacial Surgeons. J Bone Metab 22:151\u2013165","journal-title":"J Bone Metab"},{"key":"890_CR14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","volume":"35","author":"T Yoneda","year":"2017","unstructured":"Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, Taguchi A, Nagata T, Urade M, Shibahara T, Toyosawa S, Japanese Allied Committee on Osteonecrosis of the Jaw (2017) Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. J Bone Miner Metab 35:6\u201319","journal-title":"J Bone Miner Metab"},{"key":"890_CR15","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","volume":"123","author":"S Fedele","year":"2010","unstructured":"Fedele S, Porter SR, D\u2019Aiuto F, Aljohani S, Vescovi P, Manfredi M, Arduino PG, Broccoletti R, Musciotto A, Di Fede O, Lazarovici TS, Campisi G, Yarom N (2010) Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med 123:1060\u20131064","journal-title":"Am J Med"},{"key":"890_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bone.2018.05.001","volume":"112","author":"S Kuroshima","year":"2018","unstructured":"Kuroshima S, Sasaki M, Nakajima K, Tamaki S, Hayano H, Sawase T (2018) Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice. Bone 112:177\u2013186","journal-title":"Bone"},{"key":"890_CR17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00774-017-0872-1","volume":"36","author":"Y Akita","year":"2018","unstructured":"Akita Y, Kuroshima S, Nakajima K, Hayano H, Kanai R, Sasaki M, Sawase T (2018) Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic\/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice. J Bone Miner Metab 36:547\u2013559","journal-title":"J Bone Miner Metab"},{"key":"890_CR18","doi-asserted-by":"crossref","first-page":"115308","DOI":"10.1016\/j.bone.2020.115308","volume":"135","author":"H Hayano","year":"2020","unstructured":"Hayano H, Kuroshima S, Sasaki M, Tamaki S, Inoue M, Ishisaki A, Sawase T (2020) Distinct immunopathology in the early stages between different antiresorptives-related osteonecrosis of the jaw-like lesions in mice. Bone 135:115308","journal-title":"Bone"},{"issue":"Suppl 18","key":"890_CR19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/clr.13282","volume":"29","author":"A Stavropoulos","year":"2018","unstructured":"Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Schi\u00f8dt M, Klinge B (2018) The effect of antiresorptive drugs on implant therapy: systematic review and meta-analysis. Clin Oral Implants Res 29(Suppl 18):54\u201392","journal-title":"Clin Oral Implants Res"},{"key":"890_CR20","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, M\u00fcller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25:1468\u20131486","journal-title":"J Bone Miner Res"},{"key":"890_CR21","doi-asserted-by":"crossref","first-page":"115560","DOI":"10.1016\/j.bone.2020.115560","volume":"141","author":"S Tamaki","year":"2020","unstructured":"Tamaki S, Kuroshima S, Hayano H, Nakajima K, Kakehashi H, Ishisaki A, Sawase T (2020) Dynamic polarization shifting from M1 to M2 macrophages in reduced osteonecrosis of the jaw-like lesions by cessation of anti-RANKL antibody in mice. Bone 141:115560","journal-title":"Bone"},{"key":"890_CR22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jbmr.3292","volume":"33","author":"S Kuroshima","year":"2018","unstructured":"Kuroshima S, Sasaki M, Nakajima K, Tamaki S, Hayano H, Sawase T (2018) Transplantation of noncultured stromal vascular fraction cells of adipose tissue ameliorates osteonecrosis of the jaw-like lesions in mice. J Bone Miner Res 33:154\u2013166","journal-title":"J Bone Miner Res"},{"key":"890_CR23","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1158\/1078-0432.CCR-10-1614","volume":"17","author":"J Yamashita","year":"2011","unstructured":"Yamashita J, Koi K, Yang DY, McCauley LK (2011) Effect of zoledronate on oral wound healing in rats. Clin Cancer Res 17:1405\u20131414","journal-title":"Clin Cancer Res"},{"key":"890_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/en.2011-1439","volume":"153","author":"S Kuroshima","year":"2012","unstructured":"Kuroshima S, Go VA, Yamashita J (2012) Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice. Endocrinology 153:17\u201328","journal-title":"Endocrinology"},{"key":"890_CR25","first-page":"2394","volume":"9","author":"A Ibrahim","year":"2003","unstructured":"Ibrahim A, Scher N, Williams G, Sridhara R, Li N, Chen G, Leighton J, Booth B, Gobburu JV, Rahman A, Hsieh Y, Wood R, Vause D, Pazdur R (2003) Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases. Clin Cancer Res 9:2394\u20132399","journal-title":"Clin Cancer Res"},{"key":"890_CR26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jnci\/djk054","volume":"99","author":"F Daubin\u00e9","year":"2007","unstructured":"Daubin\u00e9 F, Le Gall C, Gasser J, Green J, Cl\u00e9zardin P (2007) Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. J Natl Cancer Inst 99:322\u2013330","journal-title":"J Natl Cancer Inst"},{"key":"890_CR27","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/jps.23136","volume":"101","author":"H Katsumi","year":"2012","unstructured":"Katsumi H, Liu S, Tanaka Y, Hitomi K, Hayashi R, Hirai Y, Kusamori K, Quan YS, Kamiyama F, Sakane T, Yamamoto A (2012) Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats. J Pharm Sci 101:3230\u20133238","journal-title":"J Pharm Sci"},{"key":"890_CR28","doi-asserted-by":"crossref","first-page":"e19389","DOI":"10.1371\/journal.pone.0019389","volume":"6","author":"TT Hung","year":"2011","unstructured":"Hung TT, Chan J, Russell PJ, Power CA (2011) Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model. PLoS One 6:e19389","journal-title":"PLoS One"},{"key":"890_CR29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2013.05.013","volume":"56","author":"S Kuroshima","year":"2013","unstructured":"Kuroshima S, Yamashita J (2013) Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice. Bone 56:101\u2013109","journal-title":"Bone"},{"key":"890_CR30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00774-009-0128-9","volume":"28","author":"Y Kobayashi","year":"2010","unstructured":"Kobayashi Y, Hiraga T, Ueda A, Wang L, Matsumoto-Nakano M, Hata K, Yatani H, Yoneda T (2010) Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice. J Bone Miner Metab 28:165\u2013175","journal-title":"J Bone Miner Metab"},{"key":"890_CR31","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jbmr.37","volume":"25","author":"T Kikuiri","year":"2010","unstructured":"Kikuiri T, Kim I, Yamaza T, Akiyama K, Zhang Q, Li Y, Chen C, Chen W, Wang S, Le AD, Shi S (2010) Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. J Bone Miner Res 25:1668\u20131679","journal-title":"J Bone Miner Res"},{"key":"890_CR32","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jbmr.1894","volume":"28","author":"B Kang","year":"2013","unstructured":"Kang B, Cheong S, Chaichanasakul T, Bezouglaia O, Atti E, Dry SM, Pirih FQ, Aghaloo TL, Tetradis S (2013) Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice. J Bone Miner Res 28:1631\u20131640","journal-title":"J Bone Miner Res"},{"key":"890_CR33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00223-012-9649-7","volume":"91","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Wang L, Liu Y, Akiyama K, Chen C, Atsuta I, Zhou T, Duan X, Jin Y, Shi S (2012) Technetium-99 conjugated with methylene diphosphonate ameliorates ovariectomy-induced osteoporotic phenotype without causing osteonecrosis in the jaw. Calcif Tissue Int 91:400\u2013408","journal-title":"Calcif Tissue Int"},{"key":"890_CR34","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","volume":"37","author":"N Yarom","year":"2019","unstructured":"Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL, Migliorati CA, Khan A, Morrison A, Anderson H, Murphy BA, Alston-Johnson D, Mendes RA, Beadle BM, Jensen SB, Saunders DP (2019) Medication-related osteonecrosis of the Jaw: MASCC\/ISOO\/ASCO clinical practice guideline. J Clin Oncol 37:2270\u20132290","journal-title":"J Clin Oncol"},{"key":"890_CR35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.archoralbio.2010.11.003","volume":"56","author":"MJ Ravosa","year":"2011","unstructured":"Ravosa MJ, Ning J, Liu Y, Stack MS (2011) Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts. Arch Oral Biol 56:491\u2013498","journal-title":"Arch Oral Biol"},{"key":"890_CR36","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3390\/ma13092086","volume":"13","author":"G Bullock","year":"2020","unstructured":"Bullock G, Miller C, McKechnie A, Hearnden V (2020) Synthetic hydroxyapatite inhibits bisphosphonate toxicity to the oral mucosa in vitro. Mater (Basel) 13:2086","journal-title":"Mater (Basel)"},{"key":"890_CR37","doi-asserted-by":"crossref","first-page":"20002","DOI":"10.18632\/oncotarget.4755","volume":"6","author":"HC Tseng","year":"2015","unstructured":"Tseng HC, Kanayama K, Kaur K, Park SH, Park S, Kozlowska A, Sun S, McKenna CE, Nishimura I, Jewett A (2015) Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation. Oncotarget 6:20002\u201320025","journal-title":"Oncotarget"},{"key":"890_CR38","doi-asserted-by":"crossref","first-page":"17349","DOI":"10.1074\/jbc.M115.652305","volume":"290","author":"S Park","year":"2015","unstructured":"Park S, Kanayama K, Kaur K, Tseng HC, Banankhah S, Quje DT, Sayre JW, Jewett A, Nishimura I (2015) Osteonecrosis of the jaw developed in mice: disease variants regulated By \u03b3\u03b4 T cells in oral mucosal barrier immunitY. J Biol Chem 290:17349\u201317366","journal-title":"J Biol Chem"},{"key":"890_CR39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bone.2019.03.031","volume":"123","author":"I Gkouveris","year":"2019","unstructured":"Gkouveris I, Hadaya D, Soundia A, Bezouglaia O, Chau Y, Dry SM, Pirih FQ, Aghaloo TL, Tetradis S (2019) Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ). Bone 123:234\u2013245","journal-title":"Bone"},{"key":"890_CR40","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1158\/1078-0432.CCR-09-0426","volume":"15","author":"S Pozzi","year":"2009","unstructured":"Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T, Schoonmaker J, Xie W, Hideshima T, Weller E, Bouxsein ML, Munshi NC, Anderson KC, Raje N (2009) High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. Clin Cancer Res 15:5829\u20135839","journal-title":"Clin Cancer Res"},{"key":"890_CR41","doi-asserted-by":"crossref","first-page":"e0128021","DOI":"10.1371\/journal.pone.0128021","volume":"10","author":"AE Vieira","year":"2015","unstructured":"Vieira AE, Repeke CE, Ferreira Junior SEB, Colavite PM, Biguetti CC, Oliveira RC, Assis GF, Taga R, Trombone AP, Garlet GP (2015) Intramembranous bone healing process subsequent to tooth extraction in mice: micro-computed tomography, histomorphometric and molecular characterization. PLoS One 10:e0128021","journal-title":"PLoS One"},{"key":"890_CR42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.oooo.2018.08.005","volume":"126","author":"A Soundia","year":"2018","unstructured":"Soundia A, Hadaya D, Mallya SM, Aghaloo TL, Tetradis S (2018) Radiographic predictors of bone exposure in patients with stage 0 medication-related osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol 126:537\u2013544","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"890_CR43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12967-017-1230-8","volume":"15","author":"C Gross","year":"2017","unstructured":"Gross C, Weber M, Creutzburg K, M\u00f6bius P, Preidl R, Amann K, Wehrhan F (2017) Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis. J Transl Med 15:128","journal-title":"J Transl Med"},{"key":"890_CR44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJMoa0802633","volume":"360","author":"RS Weinstein","year":"2009","unstructured":"Weinstein RS, Roberson PK, Manolagas SC (2009) Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med 360:53\u201362","journal-title":"N Engl J Med"},{"key":"890_CR45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrrheum.2009.87","volume":"5","author":"N Jain","year":"2009","unstructured":"Jain N, Weinstein RS (2009) Giant osteoclasts after long-term bisphosphonate therapy: diagnostic challenges. Nat Rev Rheumatol 5:341\u2013346","journal-title":"Nat Rev Rheumatol"},{"key":"890_CR46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1472-6890-14-31","volume":"14","author":"F Mac-Way","year":"2014","unstructured":"Mac-Way F, Trombetti A, Noel C, Lafage-Proust MH (2014) Giant osteoclasts in patients under bisphosphonates. BMC Clin Pathol 14:31","journal-title":"BMC Clin Pathol"},{"key":"890_CR47","doi-asserted-by":"crossref","first-page":"e0214173","DOI":"10.1371\/journal.pone.0214173","volume":"14","author":"CC Biguetti","year":"2019","unstructured":"Biguetti CC, De Oliva AH, Healy K, Mahmoud RH, Cust\u00f3dio IDC, Constantino DH, Ervolino E, Duarte MAH, Fakhouri WD, Matsumoto MA (2019) Medication-related osteonecrosis of the jaws after tooth extraction in senescent female mice treated with zoledronic acid: microtomographic, histological and immunohistochemical characterization. PLoS One 14:e0214173","journal-title":"PLoS One"},{"key":"890_CR48","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jcms.2017.02.002","volume":"45","author":"MA Matsumoto","year":"2017","unstructured":"Matsumoto MA, de Abreu Furquim EM, Gon\u00e7alves A, Santiago-J\u00fanior JF, Saraiva PP, Cardoso CL, Munerato MS, Okamoto R (2017) Aged rats under zoledronic acid therapy and oral surgery. J Craniomaxillofac Surg 45:781\u2013787","journal-title":"J Craniomaxillofac Surg"},{"key":"890_CR49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s002230010047","volume":"70","author":"A Alakangas","year":"2002","unstructured":"Alakangas A, Selander K, Mulari M, Halleen J, Lehenkari P, M\u00f6nkk\u00f6nen J, Salo J, V\u00e4\u00e4n\u00e4nen K (2002) Alendronate disturbs vesicular trafficking in osteoclasts. Calcif Tissue Int 70:40\u201347","journal-title":"Calcif Tissue Int"},{"key":"890_CR50","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00198-018-4376-1","volume":"29","author":"Y Mori","year":"2018","unstructured":"Mori Y, Kasai H, Ose A, Serada M, Ishiguro M, Shiraki M, Tanigawara Y (2018) Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker. Osteoporos Int 29:1155\u20131163","journal-title":"Osteoporos Int"},{"key":"890_CR51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cid.12297","volume":"18","author":"JW Kim","year":"2016","unstructured":"Kim JW, Cha IH, Kim SJ, Kim MR (2016) Biomarkers for bisphosphonate-related osteonecrosis of the jaw. Clin Implant Dent Relat Res 18:281\u2013291","journal-title":"Clin Implant Dent Relat Res"},{"key":"890_CR52","first-page":"e542","volume":"22","author":"L Bagan","year":"2017","unstructured":"Bagan L, Jim\u00e9nez Y, Leopoldo M, Rubert A, Bagan J (2017) Serum levels of RANKL and OPG, and the RANKL\/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: are they useful biomarkers for the advanced stages of osteonecrosis? Med Oral Patol Oral Cir Bucal 22:e542\u2013e547","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"890_CR53","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/ard.62.3.196","volume":"62","author":"H Tsuboi","year":"2003","unstructured":"Tsuboi H, Matsui Y, Hayashida K, Yamane S, Maeda-Tanimura M, Nampei A, Hashimoto J, Suzuki R, Yoshikawa H, Ochi T (2003) Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage. Ann Rheum Dis 62:196\u2013203","journal-title":"Ann Rheum Dis"},{"key":"890_CR54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/odi.12204","volume":"21","author":"V Thumbigere-Math","year":"2015","unstructured":"Thumbigere-Math V, Michalowicz BS, de Jong EP, Griffin TJ, Basi DL, Hughes PJ, Tsai ML, Swenson KK, Rockwell L, Gopalakrishnan R (2015) Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw. Oral Dis 21:46\u201356","journal-title":"Oral Dis"},{"key":"890_CR55","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.joms.2011.02.065","volume":"69","author":"DL Basi","year":"2011","unstructured":"Basi DL, Hughes PJ, Thumbigere-Math V, Sabino M, Mariash A, Lunos SA, Jensen E, Gopalakrishnan R (2011) Matrix metalloproteinase-9 expression in alveolar extraction sockets of Zoledronic acid-treated rats. J Oral Maxillofac Surg 69:2698\u20132707","journal-title":"J Oral Maxillofac Surg"},{"key":"890_CR56","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jcms.2014.12.008","volume":"43","author":"FJ Manzano-Moreno","year":"2015","unstructured":"Manzano-Moreno FJ, Ramos-Torrecillas J, De Luna-Bertos E, Ruiz C, Garc\u00eda-Mart\u00ednez O (2015) High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis. J Craniomaxillofac Surg 43:396\u2013401","journal-title":"J Craniomaxillofac Surg"},{"key":"890_CR57","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00784-014-1309-z","volume":"19","author":"FJ Manzano-Moreno","year":"2015","unstructured":"Manzano-Moreno FJ, Ramos-Torrecillas J, De Luna-Bertos E, Reyes-Botella C, Ruiz C, Garc\u00eda-Mart\u00ednez O (2015) Nitrogen-containing bisphosphonates modulate the antigenic profile and inhibit the maturation and biomineralization potential of osteoblast-like cells. Clin Oral Investig 19:895\u2013902","journal-title":"Clin Oral Investig"},{"key":"890_CR58","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jcms.2010.10.007","volume":"39","author":"FP Koch","year":"2011","unstructured":"Koch FP, Merkel C, Al-Nawas B, Smeets R, Ziebart T, Walter C, Wagner W (2011) Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner\u2013a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2. J Craniomaxillofac Surg 39:562\u2013569","journal-title":"J Craniomaxillofac Surg"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-021-00890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-021-00890-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-021-00890-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T19:10:15Z","timestamp":1641409815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-021-00890-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,7]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["890"],"URL":"https:\/\/doi.org\/10.1007\/s00223-021-00890-9","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,7]]},"assertion":[{"value":"26 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"R.K., S.K., H.K., M.S., A.I. and T.S declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal studies were performed in accordance with protocols approved by the Institutional Committee on Animal Resources.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Animal care and experimental procedures were performed in accordance with the Guidelines for Animal Experimentation of Nagasaki University, with approval from the Ethics Committee for Animal Research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}